Member Info for ZzTop1

Great Post Chiron. Thank you for sharing

AlwaysDerampimg, you've never backed anything up with research or evidence and therefore lack credibility. I'm guessing you're an equally selfish twat in person.

195 countries
7.8 Bn worldwide population

Something tells me Avacta won't have much trouble selling every test it can manufacture.

I hope you're right although 5% intraday swing either way is fairly standard

No MFM we won't as we're comparing competitors which is advisable when investing

Awww we're so sorry AW, we miss you and we really hope you feel OK. Please don't stop shorting and spreading fear for your own financial benefit, all is forgiven. We all really hope you'll take your time and seek help following your humiliation this morning. Let us know if you want to talk it through

Just concerned xx

Hahaha love it, Always losing his ****.

Calm down you sad mug. And if you honestly think you can affect the sp through this bb you're a complete muppet.

Great news coming soon unless you're shorting...

When will we hit 50p Always? Still waiting

Nice find Chiron and all healthy debate. My view, what's a few new posts at BBI? To manage the expected "very high demand" we will need a few new global manufacturing partners. That's the real news we're waiting for which we suspect will drop following validation but sure would be nice to receive beforehand.

Why £20 to £30? We're excited, let's make it £100!!

Sorry people, let's get a grip. All good to think big but PLEASE DYOR. Not deramping, just saying to throw these numbers around without the information to back it up is just guess work. Gla.

And "we're ramping up" which would suggest the manufacturing and volume will be dealt with.

Saliva + 10mins + home use

We tick all 3

Meanwhile in the US, SalivaDirect received emergency FDA approval in just over 4 weeks:

https://arstechnica-com.cdn.ampproject.org/v/s/arstechnica.com/science/2020/08/covid-spit-test-is-faster-cheaper-avoids-shortages-and-now-greenlit-by-fda/?amp_js_v=a3&_gsa=1&=1&usqp=mq331AQFKAGwASA%3D#referrer=https%3A%2F%2Fwww.google.com&_tf=From%20%251%24s&share=https%3A%2F%2Farstechnica.com%2Fscience%2F2020%2F08%2Fcovid-spit-test-is-faster-cheaper-avoids-shortages-and-now-greenlit-by-fda%2F

I like this part:

It is a very exciting time for Avacta and I look forward to keeping the market updated on progress as we realise the enormous potential in the Group

Sorry last response on the wrong thread.

On this thread, worth reading Myles Mcnulties 3rd and final paper on twitter

Clinical validation and gold standard results will move this sp and moreso on the lfd side than Bams. Until then expect the usual games.

I remember Al saying in an interview weeks ago that the manufacturing partners he had been in discussion with are up for the challenge of mass production. No doubt in my mind that future manufacturing partners have already been lined up.

To keep this information from all of the potential competitors and Al would rather the clinical validation process confirm the numbers. Wise move.

https://avacta.com/diagnostics/affimer-applications/affimer-immunoassay-reagents/sandwich-elisa/

Orasure saying their (lower nasal) antigen test due 4th quarter. First mover race is on:

https://www.globenewswire.com/news-release/2020/08/05/2073582/0/en/OraSure-Technologies-Inc-Announces-2020-Second-Quarter-Financial-Results-and-Update-on-COVID-19-Testing-Programs.html